These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26307683)

  • 1. Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence.
    Zhou N; Yuan S; Wang R; Zhang W; Chen JJ
    Oncotarget; 2015 Oct; 6(31):30745-61. PubMed ID: 26307683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1.
    Zhang W; Chen H; Chen Y; Liu J; Wang X; Yu X; Chen JJ; Zhao W
    Oncotarget; 2015 Mar; 6(7):5253-62. PubMed ID: 25650660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.
    Zhou Y; Zhang Q; Gao G; Zhang X; Liu Y; Yuan S; Wang X; Chen JJ
    J Virol; 2016 Jul; 90(13):6071-6084. PubMed ID: 27099318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy.
    Becker W
    FEBS J; 2018 Apr; 285(7):1203-1211. PubMed ID: 29193696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R; Kausar H; Munjal C; Gupta RC
    Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
    Maher DM; Bell MC; O'Donnell EA; Gupta BK; Jaggi M; Chauhan SC
    Mol Carcinog; 2011 Jan; 50(1):47-57. PubMed ID: 21061268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha.
    Boccardo E; Manzini Baldi CV; Carvalho AF; Rabachini T; Torres C; Barreta LA; Brentani H; Villa LL
    Carcinogenesis; 2010 Mar; 31(3):521-31. PubMed ID: 20042637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold-inducible RNA-binding protein (Cirp) interacts with Dyrk1b/Mirk and promotes proliferation of immature male germ cells in mice.
    Masuda T; Itoh K; Higashitsuji H; Higashitsuji H; Nakazawa N; Sakurai T; Liu Y; Tokuchi H; Fujita T; Zhao Y; Nishiyama H; Tanaka T; Fukumoto M; Ikawa M; Okabe M; Fujita J
    Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10885-90. PubMed ID: 22711815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.
    Banerjee NS; Genovese NJ; Noya F; Chien WM; Broker TR; Chow LT
    J Virol; 2006 Jul; 80(13):6517-24. PubMed ID: 16775338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of RCC1 on Serine 11 Facilitates G1/S Transition in HPV E7-Expressing Cells.
    Hou X; Qiao L; Liu R; Han X; Zhang W
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).
    Ashford AL; Oxley D; Kettle J; Hudson K; Guichard S; Cook SJ; Lochhead PA
    Biochem J; 2014 Jan; 457(1):43-56. PubMed ID: 24134204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties.
    Leder S; Czajkowska H; Maenz B; De Graaf K; Barthel A; Joost HG; Becker W
    Biochem J; 2003 Jun; 372(Pt 3):881-8. PubMed ID: 12633499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium.
    Ruesch MN; Laimins LA
    Virology; 1998 Oct; 250(1):19-29. PubMed ID: 9770416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.
    Chien WM; Parker JN; Schmidt-Grimminger DC; Broker TR; Chow LT
    Cell Growth Differ; 2000 Aug; 11(8):425-35. PubMed ID: 10965847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis.
    Chen Y; Wang S; He Z; Sun F; Huang Y; Ni Q; Wang H; Wang Y; Cheng C
    Hum Pathol; 2017 Aug; 66():48-58. PubMed ID: 28554575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.
    Toussaint-Smith E; Donner DB; Roman A
    Oncogene; 2004 Apr; 23(17):2988-95. PubMed ID: 14968115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block.
    Nor Rashid N; Yong ZL; Yusof R; Watson RJ
    Virol J; 2016 Jan; 13():2. PubMed ID: 26728921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
    Hu J; Deng H; Friedman EA
    Int J Cancer; 2013 May; 132(10):2258-69. PubMed ID: 23114871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.